Characteristics | Â | N | R | P |
---|---|---|---|---|
IL-1α (pg/ml)b | 153.59 (112.47, 166.71) | 31 | 0.085 | 0.649 |
IL-1β (pg/ml)b | 48.20 (45.56, 55.00) | 31 | 0.018 | 0.924 |
TNF-α (pg/ml)a | 64.75 ± 15.18 | 31 | 0.045 | 0.811 |
IFN-γ (pg/ml)a | 520.60 ± 248.14 | 31 | 0.017 | 0.928 |
IL-6 (ng/ml)b | 37.29 (31.43, 40.99) | 31 |  − 0.058 | 0.757 |
IL-8 (pg/ml)b | 1641.11 (1342.50, 1875.83) | 31 | 0.049 | 0.793 |
CRP (mg/L)b | 18.10 (5.10, 46.30) | 31 |  − 0.231 | 0.210 |
ESR (mm/h)a | 60.58 ± 34.74 | 31 | 0.005 | 0.980 |
ASO (lu/mL)b | 25.04 (10.58, 43.73) | 31 | 0.416 | 0.020* |
C3 (g/L)a | 1.25 ± 0.23 | 30 | 0.097 | 0.611 |
C4 (g/L)a | 0.27 ± 0.07 | 30 |  − 0.349 | 0.059 |
DAS28-CRPa | 4.05 ± 1.23 | 31 | 0.043 | 0.817 |
Disease duration (month)b | 108.00 (24.00, 192.00) | 31 |  − 0.350 | 0.054 |
Swollen jointsb | 8.00 (2.00, 10.00) | 31 |  − 0.120 | 0.521 |
Tender jointsa | 7.03 ± 4.79 | 31 |  − 0.051 | 0.787 |